TEM:NASDAQ
Tempus AI Inc
$68.22
arrow_upward
+0.34%(+0.23) 1D
$68.43
arrow_upward
+0.31% (+0.21)todayPre-market
Closed: Oct 13, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TEM...
Open
$67.12
High
$68.78
Low
$66.17
Mkt. cap
12.31B
Avg. vol.
7.11M
Volume
14.31K
52-wk high
$97.25
52-wk low
$40.77
EPS
-$1.43
Shares outstanding
175.39M
No. of employees
4K
Open
$67.12
High
$68.78
Low
$66.17
Mkt. cap
12.31B
Avg. vol.
7.11M
Volume
14.31K
52-wk high
$97.25
52-wk low
$40.77
EPS
-$1.43
Shares outstanding
175.39M
No. of employees
4K
News stories
From web sources and news partners
MarketBeat
·
10 hours ago
64,287 Shares in Tempus AI, Inc. $TEM Purchased by Fagan Associates Inc.
Simply Wall Street
·
1 day ago
Is Expanded Cancer Therapy Collaboration Altering The Investment Case For Tempus AI (TEM)?
Profile
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." Wikipedia
About Tempus AI Inc
CEOEric Lefkofsky
Employees3.8K
Founded2015
HeadquartersChicago, Illinois, United States
SectorHealth care
Websitetempus.com